NCT03390465View on ClinicalTrials.gov

Drug Interaction Study of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 15, 2017

Primary Completion Date

January 16, 2018

Study Completion Date

January 30, 2018

Conditions
Drug-Drug Interaction
Interventions
DRUG

Fimasartan/Amlodipine combination drug, Hydrochlorothiazide

Fimasartan/Amlodipine combination drug, Hydrochlorothiazide

Trial Locations (1)

Unknown

Inje University Busan Paik Hospital, Busan

Sponsors
All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY

NCT03390465 - Drug Interaction Study of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male Subjects | Biotech Hunter | Biotech Hunter